← FDA Drug Approvals (Drugs@FDA)

LUMIGAN

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2001-03-16

Drug application

FDA Application #
NDA021275
Application type
New Drug Application
Brand name
LUMIGAN
Generic name
Bimatoprost
Active ingredients
BIMATOPROST
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Discontinued
Sponsor
ABBVIE
First approval
2001-03-16

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown